- 专利标题： Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
-
申请号： US10974049申请日： 2004-10-25
-
公开(公告)号： US07141578B2公开(公告)日： 2006-11-28
- 发明人: Mark E. Salvati , James Aaron Balog , Dacia A. Pickering , Sören Giese , Aberra Fura , Wenying Li , Ramesh N. Patel , Ronald L. Hanson , Toomas Mitt , Jacques Y. Roberge , James R. Corte , Steven H. Spergel , Richard A. Rampulla , Raj N. Misra , Hai-Yun Xiao
- 申请人： Mark E. Salvati , James Aaron Balog , Dacia A. Pickering , Sören Giese , Aberra Fura , Wenying Li , Ramesh N. Patel , Ronald L. Hanson , Toomas Mitt , Jacques Y. Roberge , James R. Corte , Steven H. Spergel , Richard A. Rampulla , Raj N. Misra , Hai-Yun Xiao
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Suzanne E. Babajko; Anastasia P. Winslow
- 主分类号： A61K31/44
- IPC分类号： A61K31/44 ; A61K31/40 ; C07D491/00 ; C07D487/00
摘要：
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.